What question did this study set out to answer?

This research aims to assess the effects of nanoencapsulation on the antibacterial and anticancer properties of Rhodiola rosea extract.

February 28, 2026Open Access

Nanoencapsulation of Rhodiola rosea extract into 2-hydroxypropyl-β-cyclodextrin: enhanced antibacterial and anticancer activities

Key Points

This research aims to assess the effects of nanoencapsulation on the antibacterial and anticancer properties of Rhodiola rosea extract.
Encapsulated Rhodiola rosea extract in 2-hydroxypropyl-β-cyclodextrin (HPβCD)
Conducted cytotoxicity assays using A375 human melanoma cells
Tested antimicrobial activity against Pseudomonas putida, Escherichia coli, and Staphylococcus aureus
Nanoencapsulation significantly increased cytotoxicity against A375 cells
Enhanced antimicrobial activity observed against all tested bacteria
Indicates potential for improved therapeutic applications in cancer and infections.

Abstract

Encapsulation of Rhodiola rosea methanolic extract into HPβCD enhances its cytotoxicity against human melanoma (A375) cells and its antimicrobial activity against Pseudomonas putida , Escherichia coli , and Staphylococcus aureus .

Bookmark

View Full Paper

Cite This Study

Khorshed et al. (Thu,) studied this question.

synapsesocial.com/papers/69a286950a974eb0d3c01afb https://doi.org/https://doi.org/10.1039/d5ra07949g

Bookmark

View Full Paper